Remove 2026 Remove Digital Health Remove Pharmaceuticals Remove Telehealth
article thumbnail

What's next for Digital Therapeutics after it all went PEAR shaped?

Lloyd Price

Pear's decline followed in Proteus Digital Health's footsteps after the company filed for bankruptcy in June 2020 having raised over $500 million in funding, a massive $1.5 Billion valuation and loss of a development deal with Otsuka Pharmaceuticals. billion by 2026, growing at a CAGR of 17.8% billion by 2028.